0 results available. Select is focused ,type to refine list, press Down to open the menu,
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and inter...
The following section summarizes insights on H. Lundbeck A/S's Net Working Capital Margin:
We've identified the following companies as similar to H. Lundbeck A/S because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Net Working Capital Margin |
|---|---|---|
| GSK plc | DB:GS71 | -82.3% |
| Novo Nordisk A/S | BRSE:NOVOB | -81.5% |
| Pfizer Inc | DB:PFE | -32.6% |
| AstraZeneca | DB:ZEG | -32.5% |
| Novartis AG | SWX:NOVN | -28.6% |
| Ipsen SA | ENXTPA:IPN | -4.4% |
| H. Lundbeck A/S | DB:LDBB | -2.7% |
| Roche Holding AG | SWX:RO | -0.2% |
| Almirall | BME:ALM | 12.7% |
| Healthcare | SECTOR:HLTH.DK | 46.5% |
| Sanofi SA | ENXTPA:SAN | 90.6% |
| Orion Oyj | DB:OFK | 130.6% |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Working Capital Margin in the efficiency category include:
Net working capital expressed as a percent of revenue.
The net working capital margin measures a company’s net working capital as a percentage of the revenue. The formula to calculate net working capital margin and an example calculation for H. Lundbeck’s trailing twelve months is outlined below:
Net Working Capital Margin = Net Working Capital / Total Revenue
−2.7% = -20.381 M / 2.95 B
The tables below summarizes H. Lundbeck’s performance over the last five years:
| Fiscal Year | Net Working Capital | Revenue | Margin |
|---|---|---|---|
| 2020-12-31 | -235.7 M | 2.374 B | −9.9% |
| 2021-12-31 | -322.4 M | 2.191 B | −14.7% |
| 2022-12-31 | -33.21 M | 2.453 B | −1.4% |
| 2023-12-31 | 50.309 M | 2.671 B | 1.9% |
| 2024-12-31 | -20.381 M | 2.95 B | −0.7% |
The tables below summarizes H. Lundbeck’s performance over the last four quarters:
| Quarter Ending | Net Working Capital | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | 117 M | 708.9 M | 16.5% |
| 2024-06-30 | 140.2 M | 731.1 M | 19.2% |
| 2024-09-30 | 131.2 M | 767.5 M | 17.1% |
| 2024-12-31 | -20.381 M | 743 M | −2.7% |
You can read more about Net Working Capital here.
The chart above depicts the distribution of net working capital margin for companies operating in the Healthcare sector in the Developed economic region. Over 1,880 companies were considered in this analysis, and 1,813 had meaningful values. The average net working capital margin of companies in the sector is -611.8% with a standard deviation of 2,914.2%.
H. Lundbeck A/S's Net Working Capital Margin of -2.7% ranks in the 44.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,889 |
| Included Constituents | 1,813 |
| Min | -34,100.0% |
| Max | 1,185.8% |
| Median | 9.7% |
| Mean | -611.8% |
| Standard Deviation | 2,914.2% |
You can find companies with similar net working capital margin using this stock screener.